ST
ARRY

Stifel Trust’s Array Biopharma Inc ARRY Stock Holding History

Stifel Trust’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$23K Hold
6,275
– – ﹤0.01% 347
2014
Q2 		$29K Hold
6,275
– – 0.01% 310
2014
Q1 		$30K Sell
6,275
-1,500
-19% -$7.54K 0.01% 318
2013
Q4 		$39K Buy
7,775
+1,275
+20% +$6.94K 0.01% 289
2013
Q3 		$41K Hold
6,500
– – 0.01% 275
2013
Q2 		$30K Buy
+6,500
New +$35K 0.01% 305

Other funds holding ARRY

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stifel Trust's ARRY Position: Q3 2014 in Review

Stifel Trust held its Array Biopharma Inc (ARRY) position steady in Q3 2014 at 6,275 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #347.

Stifel Trust first reported a position in ARRY in Q2 2013 and has held it in 6 quarters since. The position peaked at $41K in Q3 2013. 112 funds tracked by Wall St. Rank hold ARRY as of Q3 2014.

  • Stifel Trust held 6,275 shares of Array Biopharma Inc worth $23K as of Q3 2014.
  • Stifel Trust left its Array Biopharma Inc share count unchanged in Q3 2014.
  • Array Biopharma Inc made up ﹤0.01% of Stifel Trust's portfolio in Q3 2014, its #347 holding.
  • Stifel Trust first reported a position in Array Biopharma Inc in Q2 2013 and has held it in 6 quarters since.
  • Stifel Trust's Array Biopharma Inc position peaked at $41K in Q3 2013.
  • 112 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2014.

Based on Stifel Trust's 13F filing for Q3 2014, filed 14 Nov 2014.